NCT04082481View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 17, 2021

Primary Completion Date

April 29, 2022

Study Completion Date

April 29, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-988

TAK-988 tablets.

DRUG

TAK-988 Placebo

TAK-988 placebo-matching tablets.

Trial Locations (2)

84124

PRA Health Sciences - Salt Lake City, Millcreek

91206

Parexel Internalional - Glendale, Glendale

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04082481 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants | Biotech Hunter | Biotech Hunter